MHRA17 Aug 2026
National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators: Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA)
The Medicines and Healthcare products Regulatory Agency published a recall notice for National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators: Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA) on 17 Aug 2026. It is one of 17 notices of this kind from MHRA since 26 Mar 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Medicines and Healthcare products Regulatory Agency
- Issued
- 09:30, 17 Aug 2026
- Alert class
- Patient Safety Alert
- Official source
- Medicines and Healthcare products Regulatory Agency: the notice at its source
The latest from the MHRAEvery warning and recall in the United Kingdom
Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains public sector information licensed under the Open Government Licence v3.0.
The notice as issued
ResMed has issued a Field Safety Notice regarding Astral 100 and 150 ventilators and associated Printed Circuit Board Assembly spare parts manufactured prior to October 2024. A fault in the device can cause unexpected interr…
Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. The text is the agency's, unedited. Contains public sector information licensed under the Open Government Licence v3.0.